Tedd leads scientific development of the Life Edit Therapeutics gene editing platform. He has more than 20 years of biotech experience focused on gene expression and pharmaceutical discovery, and was previously Chief Scientific Officer at LifeEDIT Inc., when the company was a subsidiary of AgBiome.
Prior to this, Tedd was a Co-Founder, Vice President, and Director of Research at GrassRoots Biotechnology, which was subsequently acquired by Monsanto. In addition, he directed research for pharmaceutical discovery at Cropsolution, Inc.
Tedd received his BS in Biochemistry and Math from the University of Wisconsin, Madison and his PhD in Biochemistry from the University of California, Davis.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
